Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orasure Technologies (OSUR)
NASDAQ:OSUR
Holding OSUR?
Track your performance easily
OSUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.52 - $8.04
Previous CloseN/A
Volume226.53K
Average Volume (3M)885.39K
Market Cap
$299.12M
Enterprise Value$51.01M
Total Cash (Recent Filing)$119.12M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)26.7
Beta0.77
Next Earnings
Feb 19, 2025EPS Estimate
-0.06Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.15
Shares Outstanding74,594,154
10 Day Avg. Volume759,061
30 Day Avg. Volume885,393
Standard Deviation0.22
R-Squared0.00013
Alpha0.00773
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.33
Price to Cash Flow (P/CF)5.90
P/FCF Ratio6.00
Enterprise Value/Market Cap0.17
Enterprise Value/Revenue0.23
Enterprise Value/Gross Profit0.30
Enterprise Value/Ebitda4.66
Forecast
1Y Price Target
$4.00Price Target Upside2.56% Upside
Rating ConsensusHold
Number of Analyst Covering1
Orasure Technologies News
PremiumCompany Announcements
OraSure Technologies Acquires Sherlock Biosciences for Growth
PremiumCompany Announcements
OraSure Reports Significant Revenue Drop in Q3 2024
Ownership Overview
3.13% Insiders
19.53% Mutual Funds
0.36% Other Institutional Investors
60.51% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
OSUR FAQ
What was Orasure Technologies’s price range in the past 12 months?
Orasure Technologies lowest stock price was $3.52 and its highest was $8.04 in the past 12 months.
What is Orasure Technologies’s market cap?
Orasure Technologies’s market cap is $299.12M.
When is Orasure Technologies’s upcoming earnings report date?
Orasure Technologies’s upcoming earnings report date is Feb 19, 2025 which is in 19 days.
How were Orasure Technologies’s earnings last quarter?
Orasure Technologies released its earnings results on Nov 06, 2024. The company reported -$0.06 earnings per share for the quarter, beating the consensus estimate of -$0.077 by $0.017.
Is Orasure Technologies overvalued?
According to Wall Street analysts Orasure Technologies’s price is currently Undervalued.
Does Orasure Technologies pay dividends?
Orasure Technologies does not currently pay dividends.
What is Orasure Technologies’s EPS estimate?
Orasure Technologies’s EPS estimate is -0.06.
How many shares outstanding does Orasure Technologies have?
Orasure Technologies has 74,594,154 shares outstanding.
What happened to Orasure Technologies’s price movement after its last earnings report?
Orasure Technologies reported an EPS of -$0.06 in its last earnings report, beating expectations of -$0.077. Following the earnings report the stock price went down -3.636%.
Which hedge fund is a major shareholder of Orasure Technologies?
Currently, no hedge funds are holding shares in OSUR
---
Orasure Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$4.00 (2.56% Upside)
$4.00 (2.56% Upside)
Blogger Sentiment
Bullish
OSUR Sentiment 66%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 245.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▼ 2.0%
Last 30 Days ▲ 10.2%
Last 30 Days ▲ 10.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.68%
12-Months-Change
Fundamentals
Return on Equity
2.74%
Trailing 12-Months
Asset Growth
1.23%
Trailing 12-Months
Company Description
Orasure Technologies
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices. The DNAG segment manufactures and sells specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
---
OSUR Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mix of positive developments, such as strong growth in international diagnostics and strategic advancements like the proteomics launch, alongside challenges like the declining risk assessment business and market turmoil in consumer genomics. While strategic initiatives and innovation efforts signal potential for future growth, the financials reflect ongoing adjustments and market challenges.Read More>---
Technical Analysis
---